inotuzumab
pfizer,ucb pharmaceuticals
['leusm', 'inotuzumab']
#ash22 #leusm stelljes: vod seen in 1 pt during ino induction. only 5% febrile neutropenia. 10 underwent allohct (4 in cr, 6 after relapse), spec outcomes not mentioned. very useful to have this as an option eventually, particularly in older patients. ino full dose vs mcvd/ino 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)